Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment.

ABSTRACT:

SUBMITTER: Drees EEE 

PROVIDER: S-EPMC9257296 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature